Noom

Noom paid 56 million dollars, plus another 6 million in subscription credits, to settle a US class action over the way its subscriptions renewed and how hard they were to cancel. The same company holds a Trustpilot rating of about 4.4 stars across roughly 66,000 reviews. Both facts are true at once. A fair review has to hold them together rather than pick one.

The business underneath is a weight-loss program built on behavior-change psychology and delivered through a mobile app. Noom started in New York, grew into the best-known name in its corner of health and fitness, and has since added a telehealth arm that brings prescription medication into the same pipeline.

Food tracking is part of the package, but the real pitch is habit change: adjust what a person does every day, on the theory that the weight follows, and the company has built its whole public face around exactly that claim.

Behavior change as the product

Noom Weight is the core program, and it treats weight management as a habits problem before it is a food problem. The framing runs through the whole site: the nutrition writing, the recipe collections, the menopause material, and even the drug coverage all come back to what a person does daily. Few app companies keep that kind of thread running across so much content.

Beyond individual subscribers, employers and health plans can sponsor the program for their workforces, and that channel gets its own partner support contact, separate from regular customer service. One structural note for first-time visitors: the homepage itself is a lean app-style shell, and the substantive reading sits a level down, on the blog and the standing policy pages.

A blog archive fifty pages deep

The editorial side turns out to be bigger than the app itself lets on. Noom's blog archive runs past fifty index pages, sorted into weight management, nutrition, recipes, and menopause categories, and the cadence is live, with several new articles landing within a single recent week. Recent subjects include tart cherry juice, kale smoothie recipes, sparkling water as a weight-loss aid, and light low-carb beers, each fronted with full food photography.

The menopause category deserves its own mention: weight-loss publishers rarely give that audience a standing section, and here it sits at the same level as nutrition and recipes, with its own archive behind it.

GLP-1 medications and the telehealth arm

A large share of the current output tracks the medication era in weight loss. There are comparison pieces across Wegovy, Zepbound, Mounjaro, and Ozempic. Other entries cover side effects and dosing, and practical questions such as what to do when the scale stalls on Mounjaro or how that drug mixes with alcohol. These are the questions people bring to a search engine at midnight, and the archive meets them at that level of detail.

All of it feeds Noom Med, the telehealth offering that connects the articles to an actual medical service, and the main site keeps a standing page on GLP-1 access and transparency. I opened the Mounjaro material braced for shallow search bait and found dosing and side-effect detail concrete enough to be useful, which raised my estimate of the whole archive.

A free insurance checker

The most concrete tool on the site is an insurance checker that costs nothing to use. A visitor can check whether an insurer covers the medication or the program itself, which answers the first question most people bring to this category: what it will cost. That is a small feature with outsized practical value, since coverage often decides whether the medication route is even on the table, and it asks nothing of the visitor beyond a few minutes.

Trustpilot volume and a settlement

A 4.4-star average is unremarkable by itself. Holding it across roughly 66,000 Trustpilot reviews is the more interesting part, since ratings usually sag as volume grows and this one has held at scale; the company is also accredited by the BBB under its corporate name, Noom, Inc.

The settlement sits on the other side of the ledger. The class action covered auto-renewal and cancellation practices for an earlier generation of subscribers, and the resolution forced clearer renewal disclosures, now built into how the site presents its terms. Anyone weighing a subscription should know that history: it cost the company real money and rewrote the fine print.

Phone hours, chat, and an account portal

Contact routes are unusually visible for a subscription app. There is a customer phone line staffed daily from 8 a.m. to 8 p.m. Eastern time, in-app support chat available around the clock, and a web account portal for handling account matters directly, all laid out on Noom's support page. The company also maintains profiles on Facebook, X, Instagram, LinkedIn, and YouTube. Given what the lawsuit was about, the prominence of these routes reads like a deliberate fix, and a welcome one.

Put together, the file on Noom runs long in both directions: a recognizable method, an editorial operation with real publishing discipline, medication access with a coverage tool placed in front of it, heavy review volume, one expensive legal lesson, and support channels that take seconds to find. Neither side cancels the other out. The class action is on the record, and so is the 4.4-star average across 66,000 reviews, and any honest account of Noom has to carry both numbers at once.

---

---